The Importance of Concurrent Chemotherapy for T1 Esophageal Cancer: Role of FDG-PET/CT for Local Control
Conclusion: It is important to note that all patients with FDG-avid primary tumor in the no-CRT group developed local recurrence. This would suggest that concurrent chemotherapy is an integral part of disease management in patients with T1 esophageal squamous cell carcinoma.
Source: In Vivo - Category: Research Authors: OGINO, I., WATANABE, S., HIRASAWA, K., MISUMI, T., HATA, M., KUNISAKI, C. Tags: Clinical Studies Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | CT Scan | Esophagus Cancer | PET Scan | Research | Skin Cancer | Squamous Cell Carcinoma | Study